| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 39.24% | 6.55% | -2.86% | 0 | -56.96% | 2025-09-02 |
| 2 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 41.70% | 6.83% | -2.86% | 0 | -56.96% | 2025-09-03 |
| 3 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 40.66% | 5.85% | -2.86% | 0 | -56.96% | 2025-09-04 |
| 4 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 40.67% | 9.32% | -2.86% | 0 | -56.96% | 2025-09-05 |
| 5 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 40.59% | 6.55% | -2.86% | 0 | -56.96% | 2025-09-08 |
| 6 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 40.59% | 0.36% | -2.86% | 0 | -56.96% | 2025-09-09 |
| 7 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 38.12% | 1.05% | -2.86% | 0 | -56.96% | 2025-09-10 |
| 8 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 38.48% | 2.64% | -2.86% | 0 | -56.96% | 2025-09-11 |
| 9 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 42.41% | -3.14% | -2.86% | 0 | -56.96% | 2025-09-12 |
| 10 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 42.67% | 0.25% | -2.86% | 0 | -56.96% | 2025-09-15 |
| 11 | 李安飞 | 中信证券 | 医药生物 | 65.70% | 42.67% | 0.00% | -2.86% | 0 | -56.96% | 2025-09-16 |
| 12 | 夏禹 | 国联民生 | 医药生物 | 65.63% | 32.00% | 7.57% | 20.00% | 7 | -52.01% | 2025-11-03 |
| 13 | 刘浩 | 华创证券 | 医药生物 | 65.50% | 74.29% | 7.95% | 29.41% | 2 | -47.33% | 2025-07-10 |
| 14 | 阳景 | 浦银国际证券 | 医药生物 | 65.45% | 58.29% | 34.09% | 100.00% | 3 | 0.00% | 2025-08-13 |
| 15 | 刘浩 | 华创证券 | 医药生物 | 65.37% | 69.28% | 19.82% | 29.41% | 2 | -47.33% | 2025-07-09 |
| 16 | 阳景 | 浦银国际证券 | 医药生物 | 65.33% | 45.70% | 32.32% | 100.00% | 3 | 0.00% | 2025-08-18 |
| 17 | 李安飞 | 广发证券 | 医药生物 | 65.29% | 56.05% | 42.93% | -2.86% | 1 | -56.96% | 2025-06-13 |
| 18 | 顾资然 | 中信证券 | 医药生物 | 65.20% | 64.58% | 52.72% | 66.67% | 6 | -1.79% | 2025-08-26 |
| 19 | 李安飞 | 广发证券 | 医药生物 | 65.11% | 50.70% | 40.08% | -2.86% | 1 | -56.96% | 2025-06-09 |
| 20 | 阳景 | 浦银国际证券 | 医药生物 | 65.04% | 59.25% | 30.82% | 100.00% | 3 | 0.00% | 2025-07-31 |